- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GNI Group Ltd (2160)
Track the GNI share price today and view real-time 2160 share price data, including charts, technicals, and key financials. View the 2160 premarket stock price ahead of the market session or assess the after hours quote. Explore 2160 stock price movements, trading volume, and market activity across the TYO exchange.
What Is the GNI Stock Price Today?
The GNI stock price today is 3,440.0.
What Is the Stock Symbol for GNI?
The stock symbol for GNI is ""2160.""
What Stock Exchange Does GNI Trade On?
GNI is listed and trades on the Tokyo stock exchange.
Is GNI a Good Stock to Buy?
Determining whether GNI or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2160 quote. (ISIN: JP3386370005)
What Is the GNI Stock Price Today?
The GNI stock price today is 3,440.0.
What Is the Stock Symbol for GNI?
The stock symbol for GNI is ""2160.""
What Stock Exchange Does GNI Trade On?
GNI is listed and trades on the Tokyo stock exchange.
Is GNI a Good Stock to Buy?
Determining whether GNI or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2160 quote. (ISIN: JP3386370005)
3,440.0
+70.0(+2.08%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,355.0
3,515.0
52 wk Range
2,084.0
4,410.0
2160 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,355.03,515.0
52 wk Range
2,084.04,410.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2160 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
4,400.0
Upside
+27.91%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
GNI Group Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States. It operates in two segments, Pharmaceutical Business and Medical Equipment Business. The company offers ETUARY for the treatment of idiopathic pulmonary fibrosis; H-GENIN Crush-Mix for the treatment of bone defects; AltiPly for the treatment of acute and chronic wounds; and orthobiologics products. It also develops ETUARY which is in Phase III clinical trial for the treatment of pneumoconiosis, dermatomyositis interstitial lung disease, and systemic sclerosis-associated interstitial lung disease; and F351 which is in Phase III clinical trial for the treatment of chronic hepatitis B liver fibrosis. In addition, the company is involved in the development of ETUARY which is in Phase II clinical trial for the treatment of radiation-induced lung injury with or without immune-related pneumonitis; F573 which is in Phase II clinical trial for the treatment of acute liver failure and acute-on-chronic liver failure; F351 which is in Phase I clinical trial for the treatment of MASH-advanced liver fibrosis; and F230 which is in Phase I clinical trial for the treatment of pulmonary arterial hypertension. Further, it develops CG001419 which is in Phase Ia clinical trial for the treatment of acute and chronic pain; CG001419 which is in Phase Ia clinical trial for the treatment of solid tumors; and CG009301 which is in Phase Ia clinical trial for the treatment of leukemia and MYC+ cancers. The company was incorporated in 2001 and is headquartered in Chuo, Japan.
Compare 2160 to Peers and Sector
Metrics to compare | 2160 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2160PeersSector | |
|---|---|---|---|---|
P/E Ratio | −45.1x | −6.8x | −0.5x | |
PEG Ratio | 0.09 | −0.13 | 0.00 | |
Price/Book | 3.8x | 4.5x | 2.6x | |
Price / LTM Sales | 7.1x | 37.6x | 3.2x | |
Upside (Analyst Target) | 27.9% | 113.9% | 44.2% | |
Fair Value Upside | Unlock | 2.5% | 5.5% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4,400.0
(+27.91% Upside)
Earnings
Latest Release
13/02/2026
EPS / Forecast
-74.44 / 224.64
Revenue / Forecast
7.48B / 11.41B
People Also Watch
FAQ
What Is the GNI (2160) Stock Price Today?
The GNI stock price today is 3,440.0 JPY.
What Stock Exchange Does GNI Trade On?
GNI is listed and trades on the Tokyo Stock Exchange.
What Is the Stock Symbol for GNI?
The stock symbol for GNI is "2160."
What Is the GNI Market Cap?
As of today, GNI market cap is 191.56B JPY.
What Is GNI's Earnings Per Share (TTM)?
The GNI EPS (TTM) is -80.9.
When Is the Next GNI Earnings Date?
GNI will release its next earnings report on 15/05/2026.
From a Technical Analysis Perspective, Is 2160 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has GNI Stock Split?
GNI has split 2 times.
How Many Employees Does GNI Have?
GNI has 990 employees.
What is the current trading status of GNI (2160)?
As of 20/04/2026, GNI (2160) is trading at a price of 3,440.0 JPY, with a previous close of 3,370.0 JPY. The stock has fluctuated within a day range of 3,355.0 JPY to 3,515.0 JPY, while its 52-week range spans from 2,084.0 JPY to 4,410.0 JPY.
What Is GNI (2160) Price Target According to Analysts?
The average 12-month price target for GNI is 4,400.0 JPY, with a high estimate of 5000 JPY and a low estimate of 3800 JPY. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +27.91% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.